CCL5 and thanatophoric dysplasia: Regarding CCL5, this analysis indicated that an increase of CCL5 concentration by 100 pg/ml caused 50% increase of risk for TD development (OR = 1.005, 95% CI: 1.001–1.008, p = 0.005) (Table 2), suggesting a potential for CCL5 to be a TD risk factor.